|
|||||
|
|
Fidarestat. Sanwa Kagaku/NC Curex/Sankyo |
|
| Authors: | Giannoukakis Nick |
| Affiliation: | University of Pittsburgh School of Medicine, Diabetes Institute, 3460 Fifth Avenue, Pittsburgh, PA 15213, USA. ngiann1@pitt.edu |
| Abstract: | Fidarestat is an aldose reductase inhibitor being co-developed by Sanwa Kagaku, NC Curex (a joint venture company created by Japan Energy and Kaken) and Sankyo, for the potential treatment of diabetic neuropathy. |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |